Funding for this research was provided by:
Novo Nordisk Netherlands
Text and Data Mining valid from 2018-05-10
Received: 8 June 2017
Accepted: 30 April 2018
First Online: 10 May 2018
Ethics approval and consent to participate
: This study has been conducted in accordance with the guidelines of the Declaration of Helsinki and Good Clinical Practice. The patient data were retrospectively acquired from hospital records generated during care-as-usual. Statistical analysis was performed requiring patient anonymity in agreement with the ethics committee regulations [CitationRef removed]. According to the Dutch law on Medical Research with Human Subjects, this study has been exempted for approval by the local ethics committees and no informed consent was deemed necessary. The ethical committees of the University Medical Center Groningen and Isala Klinieken Zwolle reviewed the research and also decided that no approval is needed.
: The authors declare that they have no competing interests. Novo Nordisk Netherlands provided an unrestricted research grant for studying the WHO-1999-cohort (SHK and BHRW). The study sponsor was not involved in the designs of the study; the collection, analysis and interpretation of data; writing the report; or the decision to submit the report for publication.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.